Related Experiment Video
Updated: Mar 9, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Etiologic spectrum and functional outcome of the acute inflammatory myelitis
Edgar Carnero Contentti1, Javier Pablo Hryb2, Ana Diego2
1Department of Neurology, Hospital Carlos G. Durand, University of Buenos Aires, Av Díaz Vélez 5044, Buenos Aires, Argentina. junior.carnero@hotmail.com.
Abstract:
Clinical, neuroimaging, and laboratory features are not specific enough to establish the etiological diagnosis of the acute inflammatory myelitis (AIM). Longitudinally extensive transverse myelitis (LETM) seen on magnetic resonance imaging (MRI) has been associated with a poor functional prognosis. The aim of this study was to assess the functional outcomes of a first AIM event comparing patients with LETM vs. no LETM on MRI and to report the differential diagnosis. Clinical, radiological, biochemical aspects were collected, and Winner-Hughes Functional Disability Scale (WHFDS) was performed after 3 and 6 months. Centromedullary lesions were associated with LETM, lateral lesions with partial lesion (PL), and brain MRI lesions with multiple sclerosis and acute encephalomyelitis disseminated. LETM patients were associated with a worse functional outcome as the need of a wheelchair after 3 and 6 months (OR = 7.61 p = 0.01; OR 4.8 p = 0.04, respectively), a walker or cane (OR = 11.0 p = 0.002, OR = 4.3 p = 0.03, respectively). In addition, we found a correlation between LETM and acute complete transverse myelitis and PL with acute partial transverse myelitis (83.3 and 90.9%, respectively; p < 0.0001). In conclusion, AIM is a heterogeneous syndrome from an etiological point of view and LETM patients had worse functional prognosis compared with PL after 3 and 6 months.
Insights
Longitudinally extensive transverse myelitis (LETM) on MRI indicates a poorer functional outcome for acute inflammatory myelitis (AIM) patients. Early identification of LETM is crucial for predicting long-term disability and guiding treatment strategies.
Area of Science:
- Neurology
- Neuroimmunology
- Radiology
Background:
- Acute inflammatory myelitis (AIM) diagnosis is challenging due to non-specific clinical, neuroimaging, and laboratory findings.
- Longitudinally extensive transverse myelitis (LETM) on MRI is linked to poorer functional prognosis in AIM patients.
Purpose of the Study:
- To evaluate functional outcomes in first-time AIM events, comparing patients with and without LETM on MRI.
- To identify differential diagnoses associated with specific lesion patterns.
Main Methods:
- Retrospective analysis of clinical, radiological, and biochemical data.
- Assessment of functional outcomes using the Winner-Hughes Functional Disability Scale (WHFDS) at 3 and 6 months post-event.
- Correlation of MRI findings (LETM, lesion location) with clinical presentation and functional prognosis.
Main Results:
- LETM was associated with significantly worse functional outcomes, including increased wheelchair dependence (OR=7.61 at 3 months, OR=4.8 at 6 months) and need for mobility aids (OR=11.0 at 3 months, OR=4.3 at 6 months).
- Centromedullary lesions correlated with LETM, while lateral lesions were associated with partial transverse myelitis (PL).
- Brain MRI lesions indicated conditions like multiple sclerosis and acute disseminated encephalomyelitis.
Conclusions:
- Acute inflammatory myelitis (AIM) is an etiologically diverse condition.
- Longitudinally extensive transverse myelitis (LETM) predicts a worse functional prognosis compared to partial lesions (PL) in AIM patients at 3 and 6 months.
More Related Videos
08:17Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myocarditis III: Medical Management